Perfusion Blog

CABG PROCEDURE

7

Apr, 2016

CABG reduces 10-year mortality rate in patients with ischemic cardiomyopathy

By: | Tags: | Comments: 0

CHICAGO — Compared with medical therapy alone, CABG plus medical therapy reduced mortality rates over 10 years in patients with ischemic cardiomyopathy, according to long-term results of the STICHES trial reported at the American College of Cardiology Scientific Session. Eric J. Velazquez, MD, and colleagues randomly assigned 1,212 patients with left ventricular ejection fraction 35% and CAD suitable for CABG (mean age, 60 years; 12% women) to undergo guideline-directed medical…

READ MORE
s2Member®
×